Abstract
Four indolizine derivatives were obtained via 1,3-dipolar cycloaddition reaction of 1-(2′-benzimidazolylmethyl)pyridinium ylide with various electron-deficient alkynes. The reaction of this pyridinium N-ylide with dimethyl maleate gave an unexpected methyl 1-oxo-benzimidazo[1,2-a]pyridine-3-carboxylate. The structures of all reported compounds have been examined by X-ray crystallography and NMR spectroscopy.
1 Introduction
N-Phenacylpyridinium salts have found applications as reagents in the organic synthesis of diverse classes of substances [1–3]. Their heteroanalogues, with a heterocyclic ring such as pyridine or pyrazine instead of a phenacyl group, have been used successfully to extend the classical synthesis of indolizine derivatives [4, 5]. The use of these salts offers the advantage of removing a few reaction steps to reach the target molecule and a simple workup. Furthermore, it has recently been reconsidered as a one-pot multicomponent process [6, 7].
Previously, we have reported that bicyclic mesoionic thiazolo[3,2-a]imidazole derivatives can be formed by a reaction involving carbon disulfide and imidazolium N-ylide generated in situ from N-phenacyl-2-bromoimidazolium salts, in the presence of Et3N [8].
In continuation of our research interest in heteroaromatic N-ylides involving multicomponent reactions, we report here our results concerning the reactivity of (2′-benzimidazolylmethyl)pyridinium ylide towards both dimethyl maleate and some alkynes as dipolarophiles. Pyridone and indolizine derivatives containing a benzimidazole unit were achieved as a result of these reactions.
2 Results and discussion
In a preliminary exploratory study, a mixture of 1-[(1H-benzo[d]imidazol-2-yl)methyl] pyridinium chloride 1 (Scheme 1), which was prepared from the reaction of pyridine with 2-(chloromethyl)-1H-benzo[d]imidazole as described previously [9–11], and dimethyl acetylenedicarboxylate (DMAD) was stirred at ambient temperature using chloroform as solvent and in the presence of triethylamine for 24 h (Scheme 2).
![Scheme 1: Preparation of 1-[(1H-benzo[d]imidazol-2-yl)methyl] pyridinium chloride 1.](/document/doi/10.1515/znb-2015-0016/asset/graphic/j_znb-2015-0016_scheme_001.jpg)
Preparation of 1-[(1H-benzo[d]imidazol-2-yl)methyl] pyridinium chloride 1.

Formation of indolizines derivatives 2a-d.
After general workup, the obtained compound was fully characterized by 1H, 13C NMR, and mass spectra. The formation of indolizine 2a was further confirmed by crystal structure determination (Fig. 1). Compound 2a comes from the dehydrogenation of the initially formed cycloadduct in air. The intermediates, dihydroindolizines and tetrahydroindolizine, were not stable enough to be isolated.

Oak ridge thermal ellipsoid plots (ORTEP) of the molecular structures of 1, 2a, 2b, 2c, 2d in the crystal and atom numbering scheme adopted (displacement ellipsoids at the 50 % probability level; H atoms with arbitrary radii; blue: nitrogen, red: oxygen, yellow: chloride).
This result clearly showed that, due to the electron withdrawing ability of the pyridinium moiety, the methylene is acidic, and a 1,3-dipolar cycloaddition of the in situ generated ylide with DMAD took place. The favorable effect of the benzimidazole substituent on the intermediate carbanion stability was confirmed by comparison with a phenyl substituent. The presence of the benzimidazole group is essential, since no adducts were reported in the literature using N-benzylpyridinium chloride.
To further extend the utility of this reaction, the reactivity of other activated dipolarophiles was explored using the same procedure. Four functionalized indolizines were successfully prepared in 30–45 % yields, and their structures were confirmed by X-ray crystallography and NMR spectroscopy (Scheme 2, Fig. 1, Tables 1 and 2).
Crystal structure data for 1, 2a, 2b.
| 1 | 2a | 2b | |
|---|---|---|---|
| Formula | C13H12ClN3 | C19H15N3O4 | C21H19N3O4 |
| Mr | 245.71 | 349.34 | 377.39 |
| Crystal size, mm3 | 0.15 × 0.09 × 0.012 | 0.2 × 0.13 × 0.09 | 0.2 × 0.15 × 0.11 |
| Crystal system | Monoclinic | Monoclinic | Monoclinic |
| Space group | P21/c | P21/a | P21/c |
| a, Å | 9.6358(6) | 7.3528(17) | 7.4268(2) |
| b, Å | 9.6452(5) | 17.486(4) | 22.2753(6) |
| c, Å | 13.1453(7) | 12.406(3) | 11.2956(3) |
| β, deg | 91.813(2) | 94.332(11) | 94.9470(10) |
| V, Å3 | 1221.10(12) | 1590.5(6) | 1861.72(9) |
| Z | 4 | 4 | 4 |
| Dcalcd, g cm–3 | 1.337 | 1.459 | 1.346 |
| μ(MoKα), cm–1 | 0.293 | 0.105 | 0.095 |
| F(000), e | 512 | 728 | 792 |
| hkl range | –11 ≤ h ≤ +11 | –11 ≤ h ≤ +11 | –9 ≤ h ≤ +9 |
| –9 ≤ k ≤ +11 | –26 ≤ k ≤ +26 | –29 ≤ k ≤ +29 | |
| –16 ≤ l ≤ +15 | –18 ≤ l ≤ +14 | –11 ≤ l ≤ +14 | |
| ((sinθ)/λ)max, Å–1 | 0.618 | 0.754 | 0.657 |
| Refl. measured | 9207 | 39412 | 17988 |
| Refl. unique/Rint | 2413/0.0519 | 5667/0.0292 | 4425/0.0490 |
| Param. refined | 154 | 237 | 255 |
| R(F)/wR(F2) (I > 2σ(I)) | 0.0430/0.0853 | 0.0418/0.1099 | 0.0482/0.1052 |
| R(F)/wR(F2) (all data) | 0.0878/0.1016 | 0.0576/0.1204 | 0.0966/0.1250 |
| Goodness-of-fit on F2 | 1.000 | 1.029 | 1.012 |
| Δρfin (max/min), e Å–3 | 0.199/–0.235 | 0.456/–0.273 | 0.208/–0.199 |
Crystal structure data for 2c, 2d, 3.
| 2c | 2d | 3 | |
|---|---|---|---|
| Formula | C17H13N3O2 | C18H15N3O2 | C13H10N2O3 |
| Mr | 291.3 | 305.33 | 242.23 |
| Crystal size, mm3 | 0.19 × 0.14 × 0.1 | 0.22 × 0.17 × 0.09 | 0.14 × 0.1 × 0.08 |
| Crystal system | Monoclinic | Triclinic | Orthorhombic |
| Space group | P21/n | P1̅ | Pca21 |
| a, Å | 6.7660(17) | 6.9876(4) | 25.034(7) |
| b, Å | 16.097(4) | 9.6542(6) | 5.7033(15) |
| c, Å | 12.805(3) | 12.0140(7) | 7.7384(16) |
| α, deg | 90 | 99.948(5) | 90 |
| β, deg | 99.752(11) | 100.096(3) | 90 |
| γ, deg | 90 | 105.380(4) | 90 |
| V, Å3 | 1374.4(6) | 748.53(8) | 1104.9(5) |
| Z | 4 | 2 | 4 |
| Dcalcd, g cm–3 | 1.408 | 1.355 | 1.456 |
| μ(MoKα), cm–1 | 0.095 | 0.091 | 0.106 |
| F(000), e | 608 | 320 | 504 |
| hkl range | –9 ≤ h ≤ +8 | –8 ≤ h ≤ +8 | –32 ≤ h ≤ +32 |
| –21 ≤ k ≤ +17 | –11 ≤ k ≤ +11 | –7 ≤ k ≤ +4 | |
| –17 ≤ l ≤ +17 | –14 ≤ l ≤ +15 | –7 ≤ l ≤ +10 | |
| ((sinθ)/λ)max, Å–1 | 0.688 | 0.630 | 0.668 |
| Refl. measured | 14618 | 8928 | 5778 |
| Refl. unique/Rint | 3724/0.0628 | 2915/0.0432 | 2224/0.0347 |
| Param. refined | 200 | 210 | 164 |
| R(F)/wR(F2) (I > 2σ(I)) | 0.0405/0.0896 | 0.0499/0.1134 | 0.0391/0.0856 |
| R(F)/wR(F2) (all data) | 0.0939/0.1192 | 0.1187/0.1426 | 0.0528/0.0919 |
| Goodness-of-fit on F2 | 0.879 | 0.982 | 1.033 |
| Δρfin (max/min), e Å–3 | 0.251/–0.285 | 0.201/–0.153 | 0.235/–0.180 |
It should be mentioned that the cyclization reactions of 1 proceed to yield 2c and 2d instead of the others possible regioisomers. The position of the ester group at the indolizine unit in compounds 2c and 2d was confirmed by the structure determinations in the solid state by X-ray diffraction (Fig. 1). It could be noted that the formation of an indolizine was not observed when pyridinium N-ylide was stirred with other alkynes, such as phenylacetylene, propyne, pentyne, or hexyne.
In the following, the crystal and molecular structure of 2a shall be described in more detail (Tables 3–5). Information on the other solid-state structures may be taken from the deposited crystallographic CIF files (see below). Compound 2a crystallizes in the monoclinic crystal system (space group P21/a with Z = 4). The indolizine ring is close to planarity with a maximum deviation of 0.023(1) Å at atom C(3). The benzimidazole ring is almost planar, with a maximum deviation of 0.031(1) Å at C(19) and forms a dihedral angle with the indolizine ring of 29.88(2)°. The carbonyl group (C(7)/O(3)–O(4)), attached to C(6), forms a dihedral angle of 25.83(7)° with the plane defined by the atoms N(1), C(5)–C(6), C(11)–C(12), while the second carbonyl group (C(10)/O(1)–O(2)) attached to the C(11) atom is rotated by 47.94(5)° out of the same plane. Bond lengths and angles are in the expected range [12, 13]. The C–N bonds (N(1)–C(1) 1.382(1), N(1)–C(5) 1.393(1), N(1)–C(12) 1.392(1) Å) in compound 2a indicate partial double bond character (Table 3, Fig. 2). The packing of the molecule 2a in the crystal can be described as alternating layers parallel to the (301̅) plane. It is stabilized by N–H⋯O hydrogen bonding interactions (Table 4, Fig. 2). The carbomethoxy methyl group forms a C–H⋯π contact to both imidazole and benzene rings of an adjacent benzimidazole unit. In addition, the interaction C(18)–H(18)⋯π with an approximately 3.513(1) Å distance has also been observed (Table 5). The packing is consolidated by slipped π–π stacking with a centroid-to-centroid distance of 3.593(1) between pyrrole and pyridine rings of indolizine with symmetry operation ½ + x, ½ – y, z.
Selected bond lengths (Å), angles (deg), and dihedral angles (deg) for 2a with estimated standard deviations in parentheses.
| 2a | |
|---|---|
| Distances | |
| N(1)–C(1) | 1.3818(12) |
| N(1)–C(5) | 1.3933(13) |
| N(1)–C(12) | 1.3917(12) |
| Angles | |
| C(12)–N(1)–C(5) | 109.60(8) |
| C(1)–N(1)–C(5) | 121.62(8) |
| N(1)–C(12)–C(11) | 106.81(8) |
| N(1)–C(5)–C(6) | 107.36(8) |
![Fig. 2: View of the crystal structure of 2a in a projection along [010] showing the formation of layers parallel to the (301̅) plane of 2a. Hydrogen bonds are shown as red dashed lines (N–H⋯O) connecting these layers.](/document/doi/10.1515/znb-2015-0016/asset/graphic/j_znb-2015-0016_fig_002.jpg)
View of the crystal structure of 2a in a projection along [010] showing the formation of layers parallel to the (301̅) plane of 2a. Hydrogen bonds are shown as red dashed lines (N–H⋯O) connecting these layers.
Distances (Å) and angles (deg) of intra- and intermolecular hydrogen bonds for 2a.
| D–H⋯A | d(D–H) | d(H⋯A) | d(D–A) | ∠(D–H⋯A) | Symm. op. |
|---|---|---|---|---|---|
| N(3)–H(3N)⋯O(1) | 0.86 | 2.24 | 2.9612(13) | 142 | –x, –y + 1, –z |
| N(3)–H(3N)⋯O(1) | 0.86 | 2.15 | 2.8149(14) | 134 | x, y, z |
Intermolecular interactions C–H⋯Cg (C–H⋯π; Å, deg) operating in the crystal structure of 2a.
| C–H⋯Cg | d(C–H) | d(H⋯Cg) | d(C–Cg) | ∠(D–H⋯Cg) | Symm. op. |
|---|---|---|---|---|---|
| C(9)–H(9B)⋯Cg1 (N(2)/C(13)/N(3)/C(14)/C(19)) | 0.96 | 2.76 | 3.3609(15) | 121 | –x, –y + 2, –z + 2 |
| C(9)–H(9B)⋯Cg2 (C(14)–C(18)) | 0.96 | 2.96 | 3.8876(16) | 164 | –x, –y + 2, –z + 2 |
| C(18)–H(18)⋯Cg2 (C(14)–C(18)) | 0.93 | 2.75 | 3.5131(14) | 140 | x – 3/2, –y – 1/2, z |
Next, we tried the utility of pyridinium N-ylide for the construction of other heterocyclic moieties. We decided to test this 1,3-dipolar addition reaction in the presence of an alkene as dipolarophile. In this regard, N-pyridinium salt 1 was treated with dimethyl maleate in the presence of triethylamine as base using chloroform as solvent (Scheme 3).
![Scheme 3: Formation of 1-oxo-benzimidazo[1,2-a]pyridine-3-carboxylate.](/document/doi/10.1515/znb-2015-0016/asset/graphic/j_znb-2015-0016_scheme_003.jpg)
Formation of 1-oxo-benzimidazo[1,2-a]pyridine-3-carboxylate.
Surprisingly, and in contrast to the foregoing reaction results, when the pyridinium N-ylide was treated with dimethyl maleate, a polycyclic product 3 was generated in about 25 % of yield. Compound 3 was the main product which could be easily isolated and identified. The structure of 3 was unambiguously confirmed by a crystal structure determination (Fig. 3, Table 2).

ORTEP plot of the molecular structure of 3 in the crystal and atom numbering scheme adopted (displacement ellipsoids at the 50 % probability level; H atoms with arbitrary radii).
Although the exact mechanism of this reaction is not very clear, a plausible reaction course of pyridinium ylide with dimethyl maleate is proposed in Scheme 4. The 1-(1-(1H-benzo [d]imidazol-2-yl)-4-methoxy-2-(methoxycarbonyl)-4-oxobutyl)pyridinium chloride A was formed by a Michael addition reaction of pyridinium ylide to the dimethyl maleate. This intermediate undergoes an elimination reaction to generate the dimethyl 2-((1H-benzo[d]imidazol-2-yl)methylene)succinate B. This latter could be deprotonated by Et3N giving, via a six-membered ring N-cyclization process, the corresponding 1-oxo-benzimidazo[1,2-a]pyridine derivative 3.

Proposed mechanism for the formation of 3.
3 Conclusion
In conclusion, the 1,3-dipolar cycloaddition reactions of 1-(2′-benzimidazolylmethyl)pyridinium ylide with various electron-deficient alkynes and an alkene as dipolarophiles were investigated. Thus, the corresponding substituted indolizine derivatives were obtained in the presence of activated alkynes. Unexpectedly, the reaction of pyridinium N-ylide with dimethyl maleate gave an unexpected methyl 1-oxo-benzimidazo[1,2-a]pyridine-3-carboxylate. Further investigations of these reactions using others reagents were carried out in our laboratory.
4 Experimental section
Melting points were determined on an Electrothermal Digital Melting Point Apparatus (IA9200, Electrothermal, Stone, Staffordshire, UK) and are uncorrected. 1H NMR and 13C NMR spectra were recorded on a BRUKER 250 DXP (Bruker Instruments, Germany) and VARIAN Mercury 300 spectrometers (Varian Medical Systems, Palo Alto, CA, USA). Chemical shifts (δ values) are expressed in ppm. High-resolution mass spectra were recorded on an LC-MS instrument (Agilent 1200 LC-Agilent 6500 Accurate Mass) and were carried out at the Instituto de Química Orgánica General (Spanish National Research Council, CSIC, Madrid, Spain). Thin layer chromatography (TLC) was carried out on precoated Merck silica gel aluminum sheets 60 F254.
4.1 General reaction procedure for the synthesis of indolizines 2
A suspension of ylide (1.0 mmol) and alkyne (1.1 mmol) in chloroform was stirred at 0 °C. Triethylamine (1.3 mmol) was added dropwise, and the mixture was stirred at room temperature for 24 h. The solution was evaporated to dryness under reduced pressure, and the brown residue was chromatographed on a silica gel column.
4.2 Dimethyl 3-(1H-benzo[d]imidazol-2-yl)indolizine-1,2-dicarboxylate (2a)
Yield: 32 %; yellow solid; m.p. 189 °C. – 1H NMR ([D5]pyridine, 250 MHz): δ = 13.12 (br, 1H), 10.03 (td, 1H, J = 7.1, 7.1, 1.0 Hz), 8.26 (td, 1H, J = 9.0, 1.1 Hz), 7.86–8.02 (m, 2H), 7.45–7.37 (m, 2H), 7.21–7.15 (m, 1H), 6.88 (td, 1H, J = 7.0, 1.3 Hz), 3.88 (s, 6H). – 13C NMR ([D5]pyridine, 62.9 MHz): δ = 167.9, 164.3, 144.2, 136.9, 136.2, 128.3, 126.0, 124.1, 123.7, 120.2, 116.2, 114.9, 104.3, 53.3, 51.8. – HRMS (ESI): m/z = 350.1138 (calcd. 350.1135 for C19H16N3O4, [M+H]+).
4.3 Diethyl 3-(1H-benzo[d]imidazol-2-yl)indolizine-1,2-dicarboxylate (2b)
Yield: 30 %; yellow solid; m.p. 161 °C. – 1H NMR ([D6]DMSO, 250 MHz): δ = 12.32 (br, 1H), 9.42 (d, 1H, J = 7.1 Hz), 8.23 (d, 1H, J = 10.9 Hz), 7.74–7.70 (m, 2H), 7.42 (td, 1H, J = 6.8, 0.8 Hz), 7.32–7.28 (m, 2H), 7.14 (td, 1H, J = 6.9, 1.1 Hz), 4.43–4.22 (m, 4H), 1.33 (t, 3H, J = 7.0 Hz), 1.24 (t, 3H, J = 7.1 Hz). – 13C NMR ([D6]DMSO, 62.9 MHz): δ = 165.0, 162.7, 142.2, 139.6, 135.6, 126.9, 125.9, 123.5, 122.6, 119.0, 115.3, 114.9, 114.8, 102.3, 61.6, 60.0, 14.3, 13.8. – HRMS (ESI): m/z = 378.1454 (calcd. 378.1454 for C21H20N3O4, [M+H]+).
4.4 Methyl 3-(1H-benzo[d]imidazol-2-yl)indolizine-1-carboxylate (2c)
Yield: 45 %; white solid; m.p. 268 °C. – 1H NMR ([D6]DMSO, 300 MHz): δ = 10.23 (d, 1H, J = 7.2 Hz), 8.23 (d, 1H, J = 8.7 Hz), 8.17 (s, 1H), 7.72–7.69 (m, 1H), 7.52–7.50 (m, 1H), 7.42 (td, 1H, J = 9.3, 0.9 Hz), 7.24–7.19 (m, 3H), 3.85 (s, 3H). – 13C NMR ([D6]DMSO, 75 MHz): δ = 164.5, 145.9, 144.0, 137.5, 134.3, 128.5, 125.6, 123.3, 122.3, 119.4, 119.1, 118.4, 116.2, 114.9, 111.4, 104.4, 51.7. – HRMS (ESI): m/z = 293.1105 (calcd. 293.1111 for C17H14N3O2, [M+H]+).
4.5 Ethyl 3-(1H-benzo[d]imidazol-2-yl)indolizine-1-carboxylate (2d)
Yield: 45 %; white solid; m.p. 165 °C. – 1H NMR ([D6]DMSO, 250 MHz): δ = 12.96 (br, 1H), 10.25 (d, 1H, J = 7.0 Hz), 8.24 (d, 1H, J = 8.9 Hz), 8.16 (s, 1H), 7.74–7.71 (m, 1H), 7.54–7.51 (m, 1H), 7.40 (td, 1H, J = 9.8, 0.9 Hz), 7.25–7.18 (m, 3H), 4.32 (q, 2H, J = 7.1 Hz), 1.35 (t, 3H, J = 4.0 Hz). – 13C NMR ([D6]DMSO, 62.5 MHz): δ = 163.5, 145.3, 143.4, 136.9, 133.7, 127.9, 124.8, 122.7, 121.6, 118.7, 118.5, 117.7, 115.5, 114.2, 110.8, 104.0, 59.5, 14.2. – HRMS (ESI): m/z = 306.1237 (calcd. 306.1243 for C18H16N3O2, [M+H]+).
4.6 Methyl 1-oxo-benzimidazo[1,2-a]pyridine-3-carboxylate (3)
Yield: 25 %; white solid; m.p. 192 °C. – 1H NMR ([D6]DMSO, 300 MHz): δ = 12.94 (br, 1H), 8.87 (d, 1H, J = 13.7 Hz), 7.67–7.55 (m, 2H), 7.38 (td, 1H, J = 8.3, 1.7 Hz), 6.67 (d, 1H, J = 1.6 Hz), 6.43 (d, 1H, J = 1.5 Hz), 3.93 (s, 3H). – 13C NMR ([D6]DMSO, 75 MHz): δ = 166.1, 159.1, 144.8, 139.4, 132.5, 127.8, 127.1, 121.7, 116.9, 111.0, 101.9, 83.7, 53.0, 114. – HRMS (ESI): m/z = 243.0760 (calcd. 243.0764 for C13H11N2O3, [M+H]+).
4.7 X-ray structure determinations
X-ray data were collected with a Bruker Apex II CCD area detector diffractometer with graphite-monochromated MoKα radiation (λ = 0.71073 Å) at 298 K. Tables 1 and 2 summarize important crystal structure data. Figures 1–3 show views of the molecular and crystal structures. Additional details of the structure determinations may be taken from the crystallographic CIF files (see the next paragraph).
CCDC 1041006, 1007307, 1041347, 1007303, 1041920, and 1007302 contain the supplementary crystallographic data for compounds 1, 2a, 2b, 2c, 2d, and 3, respectively. These data can be obtained free of charge from the Cambridge Crystallographic Data Centre viawww.ccdc.cam.ac.uk/data_request/cif.
Acknowledgments
We thank MESRS (Ministère de l’Enseignement Supérieur et de la Recherche Scientifique) and ATRST (Agence Thématique de Recherche en Sciences et Technologie), Algérie, for financial support.
References
[1] E. V. Babaev, Rev. J. Chem. 2001, 1, 161, and references cited therein.Search in Google Scholar
[2] V. Boekelheide, K. Farenholtz, J. Am. Chem. Soc. 1961, 83, 458.10.1021/ja01463a047Search in Google Scholar
[3] A. Padwa, D. J. Austin, L. Precedo, L. Zhi, J. Org. Chem. 1993, 58, 1144.10.1021/jo00057a029Search in Google Scholar
[4] J. Agejas, A. M. Cuadro, M. Pastor, J. J. Vaquero, J. L. García-Navío, J. Alvarez-Builla, Tetrahedron1995, 51, 12425.10.1016/0040-4020(95)00798-DSearch in Google Scholar
[5] J. Y. Jaung, Y. S. Jung, Bull. Korean Chem. Soc.2003, 24, 1565.Search in Google Scholar
[6] F. Dumitrascu, E. Georgescu, M. R. Caira, F. Georgescu, M. M. Popa, B. Draghici, D. G. Dumitrascu, Synlett2009, 20, 3336.10.1055/s-0029-1218372Search in Google Scholar
[7] E. Georgescu, M. R. Caira, F. Georgescu, B. Draghici, M. M. Popa, F. Dumitrascu, Synlett2009, 11, 1795.10.1055/s-0029-1217367Search in Google Scholar
[8] S. Zama, A. Bouraiou, S. Bouacida, T. Roisnel, A. Belfaitah, Tetrahedron Lett. 2013, 54, 5605.10.1016/j.tetlet.2013.08.006Search in Google Scholar
[9] A. J. Charlson, J. S. Harington, Carbohydr. Res. 1975, 43, 383.10.1016/S0008-6215(00)83505-3Search in Google Scholar
[10] E. Alcalde, L. Perez-Garcia, C. Miravitlles, J. Rius, E. Valenti, J. Org. Chem.1992, 57, 4829.10.1021/jo00044a014Search in Google Scholar
[11] A. E. Sparke, C. M. Fisher, R. E. Mewis, S. J. Archibald, Tetrahedron Lett.2010, 51, 4723.10.1016/j.tetlet.2010.07.010Search in Google Scholar
[12] M. Schulz, T. Kloubert, H. Görls, M. Westerhausen, Acta Crystallogr. 2009, E65, o957.10.1107/S1600536809011842Search in Google Scholar
[13] W.-J. Gu, J. Zhuang, Y. L. Jiang, B.-X. Wang, Acta Crystallogr. 2011, E67, o123.10.1107/S1600536810050919Search in Google Scholar
©2015 by De Gruyter
Articles in the same Issue
- Frontmatter
- In this Issue
- Synthesis, crystal structure and magnetic characterization of a cyanide-bridged Mo–Ni nanosized molecular wheel
- A novel γ-lactone derivative from the twigs of Turraea pubescens
- A cyclic mixed-valence MoVI/MoV polyoxothiomolybdate cluster anion stabilized by a [(μ-I){Ag(PPh3)3}2]+ complex cation. Preparation and structure of [(μ-I){Ag(PPh3)3}2]2 [Mo8O8(μ-OH)2(μ-OEt)6(μ-S)8(μ3-O)4{Mo(DMF)2}] · 2EtOH
- Synthesis and characterization of silver(I) complexes of thioureas and thiocyanate: crystal structure of polymeric (1,3-diazinane-2-thione)thiocyanato silver(I)
- A molecular crown analogue templated by Keggin polyanions: synthesis, structure, and electrochemical and luminescent properties
- 1-(2′-Benzimidazolylmethyl)-pyridinium ylide in the one-pot synthesis of indolizine and benzimidazo[1,2-a]pyridine derivatives
- Orthoamide und Iminiumsalze, XC. Das RIBIL-Konzept – Reaktive Iminiumsalz-basierte ionische Flüssigkeiten
- Cyclophanes, Part 73: diastereoselective dimerization of an α,β-unsaturated ketone. Structure of all-trans-1,3-dibenzoyl-2,4-di([2.2]paracyclophan-4-yl)cyclobutane
- Crystal structures and luminescence properties of two Cd(II) complexes based on 2-(1H-imidazol-1-methyl)-6-methyl-1H-benzimidazole
- Tetrahedral boronates as basic catalysts in the aldol reaction
- Design and synthesis of quinazolinyl acetamides for their analgesic and anti-inflammatory activities
- Crystal structure and photoluminescence of a new two-dimensional Cd(II) coordination polymer based on 3-(carboxymethoxy)-2-naphthoic acid
- Synthesis, anti-HIV activity and molecular modeling study of 3-aryl-6-adamantylmethyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives
Articles in the same Issue
- Frontmatter
- In this Issue
- Synthesis, crystal structure and magnetic characterization of a cyanide-bridged Mo–Ni nanosized molecular wheel
- A novel γ-lactone derivative from the twigs of Turraea pubescens
- A cyclic mixed-valence MoVI/MoV polyoxothiomolybdate cluster anion stabilized by a [(μ-I){Ag(PPh3)3}2]+ complex cation. Preparation and structure of [(μ-I){Ag(PPh3)3}2]2 [Mo8O8(μ-OH)2(μ-OEt)6(μ-S)8(μ3-O)4{Mo(DMF)2}] · 2EtOH
- Synthesis and characterization of silver(I) complexes of thioureas and thiocyanate: crystal structure of polymeric (1,3-diazinane-2-thione)thiocyanato silver(I)
- A molecular crown analogue templated by Keggin polyanions: synthesis, structure, and electrochemical and luminescent properties
- 1-(2′-Benzimidazolylmethyl)-pyridinium ylide in the one-pot synthesis of indolizine and benzimidazo[1,2-a]pyridine derivatives
- Orthoamide und Iminiumsalze, XC. Das RIBIL-Konzept – Reaktive Iminiumsalz-basierte ionische Flüssigkeiten
- Cyclophanes, Part 73: diastereoselective dimerization of an α,β-unsaturated ketone. Structure of all-trans-1,3-dibenzoyl-2,4-di([2.2]paracyclophan-4-yl)cyclobutane
- Crystal structures and luminescence properties of two Cd(II) complexes based on 2-(1H-imidazol-1-methyl)-6-methyl-1H-benzimidazole
- Tetrahedral boronates as basic catalysts in the aldol reaction
- Design and synthesis of quinazolinyl acetamides for their analgesic and anti-inflammatory activities
- Crystal structure and photoluminescence of a new two-dimensional Cd(II) coordination polymer based on 3-(carboxymethoxy)-2-naphthoic acid
- Synthesis, anti-HIV activity and molecular modeling study of 3-aryl-6-adamantylmethyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives